Related Experiment Video
Updated: Aug 15, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Brain abscess and cystic brain tumor: discrimination with dynamic susceptibility contrast perfusion-weighted MRI
Cuneyt Erdogan1, Bahattin Hakyemez, Nalan Yildirim
1Uludag University School of Medicine, Department of Radiology, Bursa, Turkey.
Abstract:
Differentiating between brain abscesses and cystic brain tumors such as high-grade gliomas and metastases is often difficult with conventional MRI. The goal of this study was to evaluate the diagnostic utility of perfusion MRI to differentiate between these pathologies. MRI was performed in 19 patients with rim-enhancing brain lesions (4 pyogenic abscesses, 8 high-grade gliomas, 7 metastases). In addition to standard MR sequences, trace diffusion-weighted MRI with apparent diffusion coefficient (ADC) maps and perfusion-weighted MRI by using a first-pass gadopentetate dimeglumine T2*-weighted gradient echo single-shot echo-planar sequence were performed. Relative cerebral blood volume (rCBV) ratios were obtained via the values of the capsular portions of the lesions and the normal white matter. All the abscesses had markedly hyperintense signals in trace diffusion images, whereas they had significant hypointense signals in ADC images. In perfusion-weighted images, the capsular portions of the abscesses demonstrated low colored areas compared with the normal white matter and the rCBV ratio calculated was 0.76 +/- 0.12 (mean +/- SD). All but two of the cystic tumors showed low signal intensity on trace diffusion-weighted images and high signal intensity on ADC maps. Hyperintense signal was found in two brain tumors mimicking brain abscesses on trace diffusion images. The rCBV values in high-grade gliomas and metastases were 5.51 +/- 2.08 and 4.58 +/- 2.19, respectively. The difference between abscesses and cystic tumors was statistically significant (P = 0.003). Perfusion MRI may allow the differentiation of pyogenic brain abscess from cystic brain tumors, making it a strong additional imaging modality in the early diagnosis of these two entities.
Insights
Perfusion MRI effectively differentiates brain abscesses from cystic brain tumors. This advanced imaging technique analyzes relative cerebral blood volume (rCBV) to distinguish between these conditions, improving early diagnosis.
Area of Science:
- Neuroradiology
- Medical Imaging
- Neuro-oncology
Background:
- Distinguishing brain abscesses from cystic brain tumors like gliomas and metastases using conventional MRI is challenging.
- Rim-enhancing lesions on MRI require accurate differentiation for appropriate patient management.
Purpose of the Study:
- To assess the diagnostic value of perfusion MRI in differentiating pyogenic brain abscesses from cystic brain tumors.
- To compare perfusion MRI characteristics, specifically relative cerebral blood volume (rCBV), between abscesses and tumors.
Main Methods:
- 19 patients with rim-enhancing brain lesions (4 abscesses, 8 high-grade gliomas, 7 metastases) underwent standard MRI, diffusion-weighted MRI (including ADC maps), and perfusion-weighted MRI.
- Relative cerebral blood volume (rCBV) ratios were calculated by comparing lesion values to normal white matter.
Main Results:
- Abscesses showed hyperintense signals on trace diffusion images and hypointense signals on ADC maps, with low rCBV ratios (0.76 ± 0.12).
- Cystic tumors generally exhibited low signal on trace diffusion and high signal on ADC maps, with significantly higher rCBV ratios (gliomas: 5.51 ± 2.08; metastases: 4.58 ± 2.19).
- The difference in rCBV between abscesses and tumors was statistically significant (P = 0.003).
Conclusions:
- Perfusion MRI, particularly rCBV analysis, is a valuable tool for differentiating pyogenic brain abscesses from cystic brain tumors.
- This modality enhances early and accurate diagnosis, guiding treatment decisions for patients with brain lesions.
Related Concept Videos
Brain Abscess l: Introduction
Magnetic Resonance Imaging
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).